Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primidone dose-finding study in amyotrophic lateral sclerosis
ChiCTR2100045741Phase 2Recruiting
- Sponsor
- Yichang First People's Hospital
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of primidone in amyotrophic lateral sclerosis (ALS) (3 arms), sponsored by Yichang First People's Hospital. Primary endpoints: Improved amyotrophic lateral sclerosis function score and Forced vital capacity. Started May 2021; status: recruiting.
02
Drugs
primidone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on ChiCTR2100045741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045741.